Cargando…
The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy
Checkpoint immunotherapy that targets inhibitory receptors of T cells, thereby reversing the functional exhaustion of T cells, marks a breakthrough in anticancer therapy. The success of T cell-directed checkpoint inhibitors of CTLA-4 and PD-1/PD-L1 has opened a new approach for cancer immunotherapy...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812684/ https://www.ncbi.nlm.nih.gov/pubmed/31681269 http://dx.doi.org/10.3389/fimmu.2019.02354 |